Both mutant p53 (r = 0.405, P < 0.0001) and c-Myc (r = 0.349, P < 0.0001) were significantly correlated with HCV-NS4 levels in HCV-infected BC patients (Fig. 3). Here, TP53 is linked to breast cancer.